Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (341-350 of 357) with videos related to

Pageof 36
Sort By:
Nature Communications|July 15, 2015
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerAndrew Stone, Elena Zotenko, Warwick J Locke, et al.
Cancer Research|February 4, 2015
Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancerVerena Thewes, Ronald Simon, Petra Schroeter, et al.
Breast Cancer Research and Treatment|February 25, 2009
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenHany Onsy Habashy, Desmond G Powe, Cindy M Staka, et al.
Tissue Antigens|April 20, 2011
Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivityL Kostenko, L Kjer-Nielsen, I Nicholson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 24, 2007
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomesEmad A Rakha, Maysa E El-Sayed, Desmond G Powe, et al.
The Journal of Small Animal Practice|August 2, 2017
The incidence of surgical site dehiscence following full-thickness gastrointestinal biopsy in dogs and cats and associated risk factorsF Swinbourne, N Jeffery, M S Tivers, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Molecular Cancer Therapeutics|May 9, 2012
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Jian Kang, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
The Journal of Small Animal Practice|November 27, 2018
Is the caudal auricular axial pattern flap robust? A multi-centre cohort study of 16 dogs and 12 cats (2005 to 2016)J L J Proot, N Jeffery, W T N Culp, et al.
Pageof 36

Showing results (341-350 of 357) with videos related to

Sort By:
Pageof 36
Nature Communications|July 15, 2015
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerAndrew Stone, Elena Zotenko, Warwick J Locke, et al.
Cancer Research|February 4, 2015
Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancerVerena Thewes, Ronald Simon, Petra Schroeter, et al.
Breast Cancer Research and Treatment|February 25, 2009
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenHany Onsy Habashy, Desmond G Powe, Cindy M Staka, et al.
Tissue Antigens|April 20, 2011
Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivityL Kostenko, L Kjer-Nielsen, I Nicholson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 24, 2007
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomesEmad A Rakha, Maysa E El-Sayed, Desmond G Powe, et al.
The Journal of Small Animal Practice|August 2, 2017
The incidence of surgical site dehiscence following full-thickness gastrointestinal biopsy in dogs and cats and associated risk factorsF Swinbourne, N Jeffery, M S Tivers, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Molecular Cancer Therapeutics|May 9, 2012
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Jian Kang, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
The Journal of Small Animal Practice|November 27, 2018
Is the caudal auricular axial pattern flap robust? A multi-centre cohort study of 16 dogs and 12 cats (2005 to 2016)J L J Proot, N Jeffery, W T N Culp, et al.
Pageof 36